Research on Supreme PLC (SUP:LON) from Equity Development
FY27 starts positively, outlook unchanged. Supreme reports good trading momentum and expects FY27 performance to be in line with market expectations as it focuses on leveraging its enlarged platform for growth. Record FY26 underpins next phase. Revenue rose 17% to £270.2m and adjusted EBITDA reached £40.6m, while the Group ended the year with £7.5m net cash despite acquisition and manufacturing investment. Drinks & Wellness continues to scale. Revenue increased 60% to £69.3m, representing 26% of Group sales, reflecting the successful integration of Clearly Drinks and SlimFast. Vaping remains well positioned. Management expects continued organic growth from 88Vape and reports it is fully prepared for the introduction of the Vaping Products Duty in October. Valuation: Fair Value remains 237p/share, with shares trading at a 41% discount.
View Full Research